UROwebinar: PARP inhibitors in prostate cancer. Part 1

Moderator(s)
Prof. Dr. D. Tilki (DE)

Presenter(s)
Prof. B. Tombal (BE)
Prof. Dr. H.G. Van Der Poel (NL)

PARP inhibitors in prostate cancer treatment is still a relatively new topic for most urologists. With this PARPi curriculum we offer urologists an educational programme addressing the following learning objectives:

1. Understanding the rationale for PARPi combinations as potential PCa treatments

2. Getting more insights on patient selection/identification for potential treatment with PARPi combinations

3. Learn the latest developments by discussing ongoing clinical trial design exploring PARPi combinations in Prostate Cancer

In a series of webinars we will tackle its role in prostate cancer treatment, discussing the latest evidence and a practical guide in how to use it in your daily practice.